According to the 'Recognizing an ADR' section, which of the following is NOT listed as a patient finding that might suggest an ADR has occurred?
Explanation
This question tests the ability to identify the specific signs and symptoms listed in the text that should prompt a nurse to consider the possibility of an ADR.
Other questions
Which of the following best defines an adverse drug reaction (ADR) as described in the text?
According to the Food and Drug Administration (FDA) classification, what is a characteristic of a Type A adverse drug reaction?
Which of the following is listed as an example of a Type B adverse drug reaction?
Which of the following factors is identified as a reason for dose-related (toxic) reactions?
The text mentions that dose-related reactions frequently implicate medications with narrow therapeutic ranges. Which of the following is listed as an example of such a medication?
When a drug-drug interaction involves one drug blocking the enzymes that metabolize a second drug, leading to an increased concentration of the second drug, what type of interaction is this?
What type of drug-drug interaction occurs when two drugs with similar therapeutic effects act together in a synergistic way, such as when warfarin and aspirin are taken together?
Which of the following medication classes is NOT listed as being more likely to result in serious drug-drug interactions?
What is a defining characteristic of an idiosyncratic reaction?
The text provides an example of cross-sensitivity in hypersensitivity reactions between which two classes of drugs?
What is a key nursing action if a patient's reaction to an agent is anaphylaxis?
What is the term used for the step of stopping a suspect medication and monitoring the patient for improvement when identifying and treating an ADR?
How does the guide, 'Davis’s Drug Guide for Nurses', visually distinguish life-threatening adverse reactions in the 'Adverse Reactions and Side Effects' section?
What is the primary purpose of the FDA MedWatch Program?
According to the FDA's definition for the MedWatch program, which of the following outcomes would classify a reaction as 'serious'?
In the U.S., where should adverse reactions to vaccines be reported?
What is the phone number for the U.S. Vaccine Adverse Event Reporting System (VAERS)?
What is the name of the Canadian body that coordinates adverse reaction reporting activities?
Based on the text, what is a possible outcome of an adverse reaction report submitted to MedEffect Canada?
A patient experiences an ADR due to an underlying illness that affects their ability to process a medication. This is an example of what kind of reaction?
What is the key difference between an adverse drug reaction (ADR) and an adverse drug event?
When managing dose-related reactions, what agent is mentioned as a treatment for digoxin toxicity?
The text lists 'frequent assessment of relevant laboratory values' as critical for preventing dose-related reactions. This is particularly important for which type of drugs?
What is the primary manifestation of idiosyncratic reactions?
What is a key step taken by the health care team when identifying and treating an ADR, specifically listed as step 3 in the text?
What is a strategy mentioned in the text for preventing ADRs in the inpatient setting?
What should a health care provider do if they encounter a product with poor packaging or labeling that could lead to an error?
What is the policy in MedEffect Canada regarding the confidentiality of the person reporting an adverse reaction?
An ADR is defined as an unexpected, undesired, or excessive response to a medication that results in specific serious outcomes. Which of the following is NOT one of those specified outcomes?
Which specific drug, when taken with cimetidine, lithium, or digoxin, is noted to potentially result in serious ADRs?
What is a crucial first step for nurses to enhance recognition of potential ADRs?
The increased central nervous system (CNS) depression that results when two drugs with CNS depressant effects potentiate each other is an example of what type of interaction?
What should a nurse do when a patient reports a history of an allergic reaction to a drug?
In what situation are dose-related reactions particularly common?
According to the text, what is a key element of preventing ADRs that 'cannot be replaced' by auxiliary strategies like computer systems?
What should a nurse do if there is uncertainty about the cause and effect relationship of a potential ADR when considering reporting to MedWatch?
What is the primary action taken after an adverse reaction report is analyzed by MedEffect Canada?
Which type of adverse drug reaction is generally considered predictable?
What is the general management strategy for a dose-related reaction?
Why is it important to document the specific type of hypersensitivity reaction a patient experiences?
What does the text suggest may explain some idiosyncratic reactions?
Which of the following is an example of a potential pharmacodynamic drug-drug interaction mentioned in the text?
What is the primary role of health care organizations in preventing ADRs, according to the 'Prevention' section?
What is the fax number for the FDA MedWatch program?
Which patient population is specifically mentioned as being at risk for dose-related reactions due to extremes in age?
A drug's concentration is unexpectedly increased because another drug has interfered with its distribution in the body. This is an example of what?
When should an adverse drug reaction be suspected?
Which of these is a key step in preventing dose-related reactions?
In the context of the FDA MedWatch program, what does the term 'disability' refer to when defining a serious reaction?